跳至主要内容
临床试验/NCT02132169
NCT02132169已完成3 期

A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 0.24% Ophthalmic Solution Used Twice Daily in Healthy Adult Subjects and in Pediatric Subjects With a History or Family History of Atopic Disease (Including Allergic Conjunctivitis)

Aciex Therapeutics, Inc.1 个研究点 分布在 1 个国家目标入组 512 人开始时间: 2014年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
512
试验地点
1
主要终点
Tolerability of AC 170 0.24% Compared to Its Vehicle at Visit 1 (Day 1)

研究概览

简要总结

The purpose of this study is to evaluate the safety of AC-170 0.24% used twice daily in Healthy Adult Subjects and in Pediatric subjects with a history or family history of atopic disease (including allergic conjunctivitis).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
2 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • at least 2 years of age
  • be able to self-administer eye drops or have a parent/legal guardian available for this purpose
  • if less than 18 years old have a history or family history of atopic disease (including allergic conjunctivitis)
  • have ocular health within normal limits

排除标准

  • known contraindications or sensitivities to the study medication or its components
  • any ocular condition that, in the opinion of the investigator, could affect the subjects safety trial parameters
  • use of disallowed medication during the period indicated prior to the enrollment or during the study

研究组 & 干预措施

AC-170 0%

Placebo Comparator

干预措施: AC-170 0% (Drug)

结局指标

主要结局

Tolerability of AC 170 0.24% Compared to Its Vehicle at Visit 1 (Day 1)

时间窗: Upon instillation, 30 Seconds Post-Instillation, 1 minute Post-Instillation

Tolerability was assessed upon instillation of study medication, at 30 seconds and 1 minute post study medication instillation. Drop comfort was assessed using a 0-to 10 scale where 0=very comfortable and 10=very uncomfortable.

Tolerability of AC 170 0.24% Compared to Its Vehicle at Visit 2 (Day 8)

时间窗: Upon instillation, 30 Seconds Post-Instillation, 1 minute Post-Instillation

Tolerability was assessed upon instillation of study medication, at 30 seconds and 1 minute post study medication instillation. Drop comfort was assessed using a 0-to 10 scale where 0=very comfortable and 10=very uncomfortable.

Tolerability of AC 170 0.24% Compared to Its Vehicle at Visit 3 (Day 22)

时间窗: Upon instillation, 30 Seconds Post-Instillation, 1 minute Post-Instillation

Tolerability was assessed upon instillation of study medication, at 30 seconds and 1 minute post study medication instillation. Drop comfort was assessed using a 0-to 10 scale where 0=very comfortable and 10=very uncomfortable.

次要结局

  • Safety of AC 170 0.024% Compared to Its Vehicle(Up to 12 Weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验